Veterinary News and Research

RSS

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

FDA warns against use of many drugs, dietary supplements due to potential contamination

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.

11 Aug 2017

Scientists take steps to inhibit impact of E. coli on human health

By understanding the functional differences between proteins expressed by two E. coli strains, researchers at Kansas State University are exploring new opportunities to inhibit their impacts to human health.

8 Aug 2017

Researchers hope to harness immune cells for better treatment of allergies, infections

By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell University research.

4 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

Researchers examine affected canines to help develop effective treatment for children with rare epilepsy

The research, published in PLOS ONE, has identified the progression of Lafora disease, a devastating form of epilepsy which affects up to 50 young children worldwide.

2 Aug 2017

Two new discoveries provide better understanding of how bacteria resist antibiotics

Two new discoveries from Edward Yu's Iowa State University laboratory are adding to the scientific understanding of how bacteria resist antibiotics.

1 Aug 2017

Bringing highly potent cell therapy products to market

There are two main challenges and both relate to manufacturing. The first one is to make sure you can manufacture therapies with reasonable costs and the second one is to make sure that you can balance the capacity you need with the demands.

31 Jul 2017

Structure of protein in salmon virus could inform strategies to treat flu in humans

The structure of a protein key to the survival and spread of a virus that affects salmon could inform strategies to treat the flu in humans, according to scientists at Rice University.

28 Jul 2017

Scientists join together to tackle increasing resistance to antibiotic treatments

A team of scientists are to pool their expertise to tackle one of the biggest health challenges facing society - the ability of common infections to resist drug treatment.

26 Jul 2017

FDA clears first MRI device for neonatal brain and head imaging

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging device specifically for neonatal brain and head imaging in neonatal intensive care units.

20 Jul 2017

Genetic therapy for two inherited neurologic diseases moves closer to human clinical trials

Researchers at University of Massachusetts Medical School and Auburn University College of Veterinary Medicine are nearing human clinical trials on a genetic therapy for two rare neurological diseases that are fatal to children.

19 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

New report proposes strategy to evaluate low-dose toxicity of endocrine disruptors

A new report by the National Academies of Sciences, Engineering, and Medicine proposes a strategy that the U.S. Environmental Protection Agency should use to evaluate the evidence of adverse human health effects from low doses of exposure to chemicals that can disrupt the endocrine system.

18 Jul 2017

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

18 Jul 2017

New research helps unravel ecological interplay of African bat, novel virus and a parasite

If there is anything scientists are certain of when it comes to bats and their supposed role in causing human disease, it is that they still have a lot to learn.

13 Jul 2017

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.

13 Jul 2017

Veterinary News and Research

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA warns against use of many drugs, dietary supplements due to potential contamination

Scientists take steps to inhibit impact of E. coli on human health

Researchers hope to harness immune cells for better treatment of allergies, infections

FDA approves new treatment for all HCV genotypes 1-6

Researchers examine affected canines to help develop effective treatment for children with rare epilepsy

Two new discoveries provide better understanding of how bacteria resist antibiotics

Bringing highly potent cell therapy products to market

Structure of protein in salmon virus could inform strategies to treat flu in humans

Scientists join together to tackle increasing resistance to antibiotic treatments

FDA clears first MRI device for neonatal brain and head imaging

Genetic therapy for two inherited neurologic diseases moves closer to human clinical trials

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

New report proposes strategy to evaluate low-dose toxicity of endocrine disruptors

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

New research helps unravel ecological interplay of African bat, novel virus and a parasite

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Herpes virus in mountain gorillas has similarity to EBV found in humans

Study estimates disease burden of congenital toxoplasmosis in Denmark

New Cornell discovery could lead to effective treatment for tuberculosis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News